Chen Y, Liu S, Yin X
Am J Cancer Res. 2025; 15(1):217-232.
PMID: 39949922
PMC: 11815372.
DOI: 10.62347/QTWJ8918.
Li J, Zhou W, Wang W
Cell Mol Life Sci. 2024; 81(1):378.
PMID: 39215816
PMC: 11365909.
DOI: 10.1007/s00018-024-05412-y.
Banerjee A, Aluganti Narasimhulu C, Singla D
Am J Physiol Heart Circ Physiol. 2023; 325(4):H751-H767.
PMID: 37594487
PMC: 10659324.
DOI: 10.1152/ajpheart.00378.2023.
Mazinani M, Rahbarizadeh F
Biomark Res. 2022; 10(1):70.
PMID: 36123710
PMC: 9487061.
DOI: 10.1186/s40364-022-00417-w.
Xu Q, Liu X, Mohseni G, Hao X, Ren Y, Xu Y
Cancer Cell Int. 2022; 22(1):242.
PMID: 35906622
PMC: 9338646.
DOI: 10.1186/s12935-022-02664-1.
Expression Dynamics of the -Glycosylated Proteins Recognized by Lectin in T Lymphocytes and Its Relationship With Moesin as an Alternative Mechanism of Cell Activation.
Gomez-Henao W, Saavedra R, Chavez-Sanchez F, Lascurain R, Zenteno E, Tenorio E
Front Immunol. 2021; 12:788880.
PMID: 34917095
PMC: 8669815.
DOI: 10.3389/fimmu.2021.788880.
Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development.
Wang Y, Zhang X, Wang Y, Zhao W, Li H, Zhang L
Acta Pharm Sin B. 2021; 11(10):2957-2972.
PMID: 34729298
PMC: 8546663.
DOI: 10.1016/j.apsb.2021.03.004.
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors.
Li X, Yang Y, Huang Q, Deng Y, Guo F, Wang G
Front Cell Dev Biol. 2021; 9:738373.
PMID: 34692696
PMC: 8529050.
DOI: 10.3389/fcell.2021.738373.
Molecular mechanisms of FasL-mediated 'reverse-signaling'.
Malarkannan S
Mol Immunol. 2020; 127:31-37.
PMID: 32905906
PMC: 7606657.
DOI: 10.1016/j.molimm.2020.08.010.
Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.
Hasan A, Selvakumar A, OReilly R
Adv Genet Eng. 2018; 4(3).
PMID: 29644163
PMC: 5891142.
Potential importance of B cells in aging and aging-associated neurodegenerative diseases.
Biragyn A, Aliseychik M, Rogaev E
Semin Immunopathol. 2017; 39(3):283-294.
PMID: 28083646
PMC: 8011659.
DOI: 10.1007/s00281-016-0615-8.
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy.
Yeku O, Brentjens R
Biochem Soc Trans. 2016; 44(2):412-8.
PMID: 27068948
PMC: 5529098.
DOI: 10.1042/BST20150291.
Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers.
Lee-Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R
J Immunol. 2016; 196(8):3385-97.
PMID: 26983789
PMC: 4821757.
DOI: 10.4049/jimmunol.1502034.
Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses.
Liu D, Burd E, Coopersmith C, Ford M
J Immunol. 2016; 196(3):1000-12.
PMID: 26729800
PMC: 4758455.
DOI: 10.4049/jimmunol.1500218.
gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.
Sasaki H, Tatemaysu T, Okuda K, Moriyama S, Yano M, Fujii Y
Mol Clin Oncol. 2014; 2(6):1035-1042.
PMID: 25279194
PMC: 4179826.
DOI: 10.3892/mco.2014.358.
Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity.
Lee-Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M
Blood. 2014; 124(9):1450-9.
PMID: 25037628
PMC: 4148767.
DOI: 10.1182/blood-2014-03-563940.
gene expression in Japanese lung cancer patients.
Sasaki H, Suzuki A, Shitara M, Hikosaka Y, Okuda K, Moriyama S
Biomed Rep. 2014; 1(1):93-96.
PMID: 24648901
PMC: 3956825.
DOI: 10.3892/br.2012.10.
SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.
Sharma R, Yolcu E, Shirwan H
Expert Rev Vaccines. 2014; 13(3):387-98.
PMID: 24521311
PMC: 4721633.
DOI: 10.1586/14760584.2014.880340.
T cell ageing: effects of age on development, survival & function.
Salam N, Rane S, Das R, Faulkner M, Gund R, Kandpal U
Indian J Med Res. 2014; 138(5):595-608.
PMID: 24434315
PMC: 3928693.
OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium.
Cunningham M, Li Z, Liu B, Yeh S, Nussenblatt R
J Ophthalmic Inflamm Infect. 2013; 3(1):12.
PMID: 23514269
PMC: 3605066.
DOI: 10.1186/1869-5760-3-12.